Metastatic squamous cell carcinoma to the heart: an unusual cause of ST elevation—a case report

Abstract Background Cardiac tumours are typically secondary in nature, and the most common malignancies metastasizing to the heart are cancers of the lung, breast, oesophagus, melanoma, and lymphoma. We present a unique case of squamous cell carcinoma of the tongue, metastasizing to the heart and manifesting with ST elevation in the inferior-leads on electrocardiogram (ECG). Case summary A 25-year-old woman was initially diagnosed with squamous cell carcinoma of the tongue at the age of 23 and treated with hemi-glossectomy with clear-margins. Sixteen months later, the tumour recurred in the oropharynx and the left upper lobe of the lung. She was treated with chemotherapy; however, the tumour progressed. Thus, she was initiated on immunotherapy and radiation therapy. One month later, she presented with chest pain. Electrocardiogram revealed ST elevation in the inferior-leads. Troponin-I was elevated. Transthoracic echocardiogram revealed focal areas of thickening within the left and right ventricular myocardium with associated hypokinesis. These findings suggested ECG changes were likely secondary to infiltrative metastases and not acute-coronary-syndrome. Cardiac magnetic resonance imaging showed infiltrative masses with increased T2-signal and heterogeneous enhancement on perfusion and delayed enhancement sequences. Imaging also demonstrated numerous extra-cardiac metastases. She was treated with analgesics and discharged to home hospice. Discussion Head and neck cancers are a rare cause of cardiac metastasis. ST elevation and troponin release are thought to be due to tumour extension into the myocardium. Cardiac metastases usually present in patients with advanced widespread malignancy. In a cancer patient with cardiac symptoms or ECG changes, it is important to consider a broad differential diagnosis and entertain the possibility of cardiac metastasis.

[1]  A. Grothey,et al.  5-fluorouracil and cardiotoxicity: a review , 2018, Therapeutic advances in medical oncology.

[2]  R. Touyz,et al.  Cardiotoxicity with vascular endothelial growth factor inhibitor therapy , 2018, npj Precision Oncology.

[3]  Joshua Schulman-Marcus,et al.  Solitary cardiac metastasis from primary oral squamous cell carcinoma presenting as ST-elevation MI , 2018, BMJ Case Reports.

[4]  K. Styczkiewicz,et al.  Tyrosine kinase inhibitors – should we worry about cardiovascular complications? , 2017 .

[5]  T. Koessler,et al.  Chemotherapy-induced Takotsubo cardiomyopathy, a case report and review of the literature , 2017, BMC Cancer.

[6]  S. Tapio Pathology and biology of radiation-induced cardiac disease , 2016, Journal of radiation research.

[7]  Hussein Tawbi,et al.  Cardiotoxicity associated with CTLA4 and PD1 blocking immunotherapy , 2016, Journal of Immunotherapy for Cancer.

[8]  W. Qureshi,et al.  Venous Thromboembolism in Cancer: An Update of Treatment and Prevention in the Era of Newer Anticoagulants , 2016, Front. Cardiovasc. Med..

[9]  A. Falanga,et al.  Cancer Tissue Procoagulant Mechanisms and the Hypercoagulable State of Patients with Cancer , 2015, Seminars in Thrombosis & Hemostasis.

[10]  A. Rennie,et al.  Cardiac metastasis of oral squamous cell carcinoma , 2015, BMJ Case Reports.

[11]  W. Busuttil,et al.  Squamous cell carcinoma of unknown origin metastasising to the right atrium causing acute heart failure , 2015, BMJ Case Reports.

[12]  D. Glancy,et al.  ST-segment elevation: Differential diagnosis, caveats , 2015, Cleveland Clinic Journal of Medicine.

[13]  U. Schoepf,et al.  Squamous cell carcinoma of the tongue with metastasis to the right ventricle. , 2015, The American journal of the medical sciences.

[14]  A. Abbate,et al.  Cardiac metastases , 2006, Journal of Clinical Pathology.

[15]  J. Banchs,et al.  Early cardiac metastasis from squamous cell carcinoma of the tongue in 2 patients. , 2012, Texas Heart Institute journal.